Skip to main content
. 2015 Mar 27;10(3):e0120511. doi: 10.1371/journal.pone.0120511

Fig 2. Correlation between PI3K/AKT/mTOR pathway alterations and prognosis by Kaplan–Meier survival analysis.

Fig 2

A. PAM activation vs. normal PAM in all patients; B. PTEN loss vs. normal PTEN in all patients; C. mutant PIK3CA vs. normal PIK3CA in all patients; D. mutant PIK3CA vs. normal PIK3CA in ER positive patients.